| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:08:14 -0700 |
| HMDB ID |
HMDB00280 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Phosphoribosyl pyrophosphate |
| Description |
Phosphoribosyl pyrophosphate (PRPP) is a pentosephosphate. The key substance in the biosynthesis of histidine, tryptophan, and purine and pyrimidine nucleotides. It is formed from ribose 5-phosphate by the enzyme ribose-phosphate diphosphokinase. It plays a role in transferring phosphate groups in several reactions. (Wikipedia). |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 5-Phospho-a-D-ribose-1-diphosphate
- 5-Phospho-a-D-ribosyl pyrophosphate
- 5-Phospho-alpha-D-ribose 1-diphosphate
- 5-Phospho-alpha-D-ribose-1-diphosphate
- 5-Phospho-alpha-D-ribosyl pyrophosphate
- 5-Phospho-alpha-D-riobse 1-diphosphate
- 5-Phospho-alpha-delta-ribose 1-diphosphate
- 5-Phospho-alpha-delta-ribose-1-diphosphate
- 5-Phospho-alpha-delta-ribosyl pyrophosphate
- 5-Phosphoribose 1-pyrophosphate
- 5-Phosphoribosyl 1-diphosphate
- 5-Phosphoribosyl a-1-pyrophosphate
- 5-Phosphoribosyl-1-pyrophosphate
- 5-Phosphorylribose 1-a-diphosphate
- 5-Phosphorylribose 1-alpha-diphosphate
- 5-Phosphorylribose 1-pyrophosphate
- 5-Phosphorylribosyl 1-pyrophosphate
- a-D-5-(Dihydrogen phosphate) 1-(trihydrogen pyrophosphate) Ribofuranose
- a-D-5-Phosphoribosyl 1-pyrophosphate
- a-D-Ribofuranose 5-phosphate 1-pyrophosphate
- a-D-Ribofuranose, 5-(dihydrogen phosphate) 1-(trihydrogen diphosphate)
- alpha-D-5-(Dihydrogen phosphate) 1-(trihydrogen pyrophosphate) Ribofuranose
- alpha-D-5-Phosphoribosyl 1-pyrophosphate
- alpha-D-Ribofuranose 5-phosphate 1-pyrophosphate
- alpha-D-Ribofuranose, 5-(dihydrogen phosphate) 1-(trihydrogen diphosphate)
- alpha-delta-5-(Dihydrogen phosphate) 1-(trihydrogen pyrophosphate) Ribofuranose
- alpha-delta-5-Phosphoribosyl 1-pyrophosphate
- alpha-delta-Ribofuranose 5-phosphate 1-pyrophosphate
- Phosphoribosyl pyrophosphate
- Phosphoribosyl-1-pyrophosphate
- Phosphoribosyl-pyrophosphate
- Phosphoribosylpyrophosphorate
- Phosphoribosylpyrophosphoric acid
- PP-Ribose-P
- PRib-PP
- PRPP
|
| Chemical Formula |
C5H13O14P3 |
| Average Molecular Weight |
390.0696 |
| Monoisotopic Molecular Weight |
389.95181466 |
| IUPAC Name |
{[(2R,3S,4R,5R)-3,4-dihydroxy-5-{[hydroxy(phosphonooxy)phosphoryl]oxy}oxolan-2-yl]methoxy}phosphonic acid |
| Traditional IUPAC Name |
[(2R,3S,4R,5R)-3,4-dihydroxy-5-{[hydroxy(phosphonooxy)phosphoryl]oxy}oxolan-2-yl]methoxyphosphonic acid |
| CAS Registry Number |
7540-64-9 |
| SMILES |
O[C@H]1[C@@H](O)[C@@H](OP(O)(=O)OP(O)(O)=O)O[C@@H]1COP(O)(O)=O |
| InChI Identifier |
InChI=1S/C5H13O14P3/c6-3-2(1-16-20(8,9)10)17-5(4(3)7)18-22(14,15)19-21(11,12)13/h2-7H,1H2,(H,14,15)(H2,8,9,10)(H2,11,12,13)/t2-,3-,4-,5-/m1/s1 |
| InChI Key |
PQGCEDQWHSBAJP-TXICZTDVSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Carbohydrates and Carbohydrate Conjugates |
| Class |
Monosaccharides |
| Sub Class |
Pentoses |
| Other Descriptors |
- 5-O-phosphono-D-ribofuranosyl diphosphate(ChEBI)
- Aliphatic Heteromonocyclic Compounds
- Monosaccharide Phosphates
- Organic Pyrophosphates
|
| Substituents |
- 1,2 Diol
- Organic Hypophosphite
- Organic Phosphite
- Oxolane
- Phosphoric Acid Ester
- Secondary Alcohol
|
| Direct Parent |
Pentoses |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
Not Available |
| Application |
Not Available |
| Cellular locations |
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
Not Available |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
Not Available
|
| Biological Properties |
| Cellular Locations |
|
| Biofluid Locations |
|
| Tissue Location |
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
5.72 +/- 0.86 uM |
Children (1-13 year old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
4.9 +/- 2.1 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
Not Available |
| Associated Disorders and Diseases |
| Disease References |
None |
| Associated OMIM IDs |
None |
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB021928 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
7062  |
| KEGG Compound ID |
C00119  |
| BioCyc ID |
PRPP  |
| BiGG ID |
33926  |
| Wikipedia Link |
Phosphoribosyl pyrophosphate  |
| NuGOwiki Link |
HMDB00280  |
| Metagene Link |
HMDB00280  |
| METLIN ID |
5274  |
| PubChem Compound |
7339  |
| PDB ID |
PRP  |
| ChEBI ID |
17111  |
| References |
| Synthesis Reference |
Gross, Akiva; Abril, Obsidiana; Lewis, Jerome M.; Geresh, Shimona; Whitesides, George M. Practical synthesis of 5-phospho-D-ribosyl a-1-pyrophosphate (PRPP): enzymatic routes from ribose 5-phosphate or ribose. Journal of the American Chemical Society (1983), 105(25), 7428-35. |
| Material Safety Data Sheet (MSDS) |
Not Available
|
| General References |
- Snyder FF, Dyer C, Seegmiller JE, Goldblum RM, Mills GC, Schmalstieg FC: Substrate inhibition of adenosine phosphorylation in adenosine deaminase deficiency and adenosine-mediated inhibition of PP-ribose-P dependent nucleotide synthesis in hypoxanthine phosphoribosyltransferase deficient erythrocytes. J Inherit Metab Dis. 1988;11(2):174-83.
Pubmed: 2459496
- Gordon RB, Keough DT, Emmerson BT: HPRT-deficiency associated with normal PRPP concentration and APRT activity. J Inherit Metab Dis. 1987;10(1):82-8.
Pubmed: 2437388
- Nishida Y, Akaoka I, Nishizawa T, Maruki M, Maruki K: Synthesis and concentration of 5-phosphoribosyl-1-pyrophosphate in erythrocytes from patients with Down's syndrome. Ann Rheum Dis. 1977 Jun;36(3):261-3.
Pubmed: 141914
- Ghitis J, Schreiber C, Waxman S: Phosphate-induced phosphoribosylpyrophosphate elevations to assess deranged folate and purine nucleotide metabolism. Proc Soc Exp Biol Med. 1987 Oct;186(1):90-5.
Pubmed: 2442765
- Yamaoka T, Yano M, Kondo M, Sasaki H, Hino S, Katashima R, Moritani M, Itakura M: Feedback inhibition of amidophosphoribosyltransferase regulates the rate of cell growth via purine nucleotide, DNA, and protein syntheses. J Biol Chem. 2001 Jun 15;276(24):21285-91. Epub 2001 Apr 4.
Pubmed: 11290738
- Blinov MN, Kamyshentsev MV, Luganova IS, Filanovskaia LI, Filippova VN: [Phosphoribosyl pyrophosphate and its metabolic enzymes in the erythrocytes in certain forms of anemia] Vopr Med Khim. 1976 Jul-Aug;22(4):456-62.
Pubmed: 194412
- Micheli V, Taddeo A: [Spectrophotometric assay of 5-phosphoribosyl-1-pyrophosphate synthetase (PRPP) in erythrocyte lysate (author's transl)] Quad Sclavo Diagn. 1981 Jun;17(2):209-15.
Pubmed: 6267652
- Sakuma R, Nishina T, Yamanaka H, Kamatani N, Nishioka K, Maeda M, Tsuji A: Phosphoribosylpyrophosphate synthetase in human erythrocytes: assay and kinetic studies using high-performance liquid chromatography. Clin Chim Acta. 1991 Dec 16;203(2-3):143-52.
Pubmed: 1663846
- Zoref-Shani E, Feinstein S, Frishberg Y, Bromberg Y, Sperling O: Kelley-Seegmiller syndrome due to a unique variant of hypoxanthine-guanine phosphoribosyltransferase: reduced affinity for 5-phosphoribosyl-1-pyrophosphate manifested only at low, physiological substrate concentrations. Biochim Biophys Acta. 2000 Feb 21;1500(2):197-203.
Pubmed: 10657589
- Sperling O, Boer P, Brosh S, Elazar E, Szeinberg A, de Vries A: Normal activity of metabolic pathways involved in the formation and utilization of phosphoribosylpyrophosphate in erythrocytes of patients with primary metabolic gout. Nutr Metab. 1975;18(4):217-23.
Pubmed: 172821
- Gorbach ZV: [Determination of phosphoribosyl pyrophosphate in the erythrocytes] Lab Delo. 1977;(12):724-5.
Pubmed: 75318
- Marcolongo R, Pompucci G, Micheli V: Familial distribution of increased erythrocyte PP-ribose-P levels. Adv Exp Med Biol. 1977;76A:280-6.
Pubmed: 193371
- Becker MA, Losman MJ, Itkin P, Simkin PA: Gout with superactive phosphoribosylpyrophosphate synthetase due to increased enzyme catalytic rate. J Lab Clin Med. 1982 Apr;99(4):495-511.
Pubmed: 6174658
- Tax WJ, Veerkamp JH: A simple and sensitive method for estimating the concentration and synthesis of 5-phosphoribosyl 1-pyrophosphate in red blood cells. Clin Chim Acta. 1977 Jul 15;78(2):209-16.
Pubmed: 195752
- MacDermot KD, Allsop J, Watts RW: The rate of purine synthesis de nova in blood mononuclear cells in vitro from patients with familial hyperuricaemic nephropathy. Clin Sci (Lond). 1984 Aug;67(2):249-58.
Pubmed: 6744792
- Emmerson BT, Gordon RB, Thompson L: Adenine phosphoribosyltransferase deficiency: its inheritance and occurrence in a female with gout and renal disease. Aust N Z J Med. 1975 Oct;5(5):440-6.
Pubmed: 1061547
- Zerez CR, Lachant NA, Tanaka KR: Decreased erythrocyte phosphoribosylpyrophosphate synthetase activity and impaired formation in thalassemia minor: a mechanism for decreased adenine nucleotide content. J Lab Clin Med. 1989 Jul;114(1):43-50.
Pubmed: 2544652
- Rylance HJ, Wallace RC, Nuki G: A method for the determination of 5-phosphoribosyl 1-pyrophosphate concentrations in erythrocytes using high-performance liquid chromatography. Anal Biochem. 1987 Feb 1;160(2):337-41.
Pubmed: 2437821
- Kane MA, Roth E, Raptis G, Schreiber C, Waxman S: Effect of intracellular folate concentration on the modulation of 5-fluorouracil cytotoxicity by the elevation of phosphoribosylpyrophosphate in cultured human KB cells. Cancer Res. 1987 Dec 15;47(24 Pt 1):6444-50.
Pubmed: 2445472
- Lachant NA, Zerez CR, Tanaka KR: Pyrimidine nucleotides impair phosphoribosylpyrophosphate (PRPP) synthetase subunit aggregation by sequestering magnesium. A mechanism for the decreased PRPP synthetase activity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency. Biochim Biophys Acta. 1989 Jan 19;994(1):81-8.
Pubmed: 2535789
|